Paris
France
11
2024-03-28
The entities that hold a legal rights for patent applications filed by inventor Albert Matthew:
Matthew Albert from Paris, FR has applied for patents for these inventions. The list has both pending applications and granted patents:
DIPEPTIDYLPEPTIDASE 4 INHIBITION ENHANCES LYMPHOCYTE TRAFFICKING, IMPROVING BOTH NATURALLY OCCURRING TUMOR IMMUNITY AND IMMUNOTHERAPY
#2 | 2022-04-21Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy
#3 | 2020-08-27Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy
#4 | 2018-08-16Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy
#5 | 2017-09-21Levels of CXCL10/IP-10 forms and soluble CD26/DPPIV activity as early predictive biomarkers for HIV/SIV associated mucosal inflammation and progression towards AIDS
#6 | 2015-09-03Levels of CXCL 10/IP-10 forms and soluble CD26/DPPIV activity as early predictive biomarkers for HIV/SIV associated mucosal inflammation and progression towards AIDS
#7 | 2015-03-12Cancer Treatment by Immunotherapy With BCG or Antigenically Related Non-Pathogenic Mycobacteria
#8 | 2012-07-05METHODS OF USING sIP-10, CD26 INHIBITORS AND CXCR3 LEVELS IN A SAMPLE TO ASSESS CLEARANCE OF INFECTION, RESPONSE TO INTERFERON THERAPY, AND TREATING CHRONIC INFECTIONS
#9 | 2010-02-18Methods of using sIP-10, CD26 inhibitors and CXCR3 levels in a sample to assess clearance of infection, response to interferon therapy, and treating chronic infections
#10 | 2008-05-22Methods of using sIP-10 to assess HCV clearance and/or response to interferon therapy
#11 | 2006-05-25Control of indoleamine 2,3 deoxygenase expression and activity
1095293 ⎘